摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R)-5-amino-2-[(R)-3-benzyloxytetradecanoylamino]pentan-1-ol | 253586-93-5

中文名称
——
中文别名
——
英文名称
(2R)-5-amino-2-[(R)-3-benzyloxytetradecanoylamino]pentan-1-ol
英文别名
(3R)-N-[(2R)-5-amino-1-hydroxypentan-2-yl]-3-phenylmethoxytetradecanamide
(2R)-5-amino-2-[(R)-3-benzyloxytetradecanoylamino]pentan-1-ol化学式
CAS
253586-93-5
化学式
C26H46N2O3
mdl
——
分子量
434.663
InChiKey
IGPABHSEKYCFIS-JWQCQUIFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    31
  • 可旋转键数:
    20
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    84.6
  • 氢给体数:
    3
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2R)-5-amino-2-[(R)-3-benzyloxytetradecanoylamino]pentan-1-ol 在 palladium on activated charcoal 2-isobutoxy-1-isobutoxycarbonyl-1,2-dihydroquinoline 、 氢气溶剂黄146 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 16.0h, 生成 O-bis(phenyloxy)phosphoryl N-[(R)-3-dodecanoyloxytetradecanoyl] DL-homoserine N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoylamino]pentyl}amide
    参考文献:
    名称:
    Synthesis and Immunobiological Activity of an Original Series of Acyclic Lipid A Mimics Based on a Pseudodipeptide Backbone
    摘要:
    N-delta-L-Homoserinyl-D-ornithinol pseudodipeptides N-acylated with typical Escherichia coli lipid A fatty acid residues and mono-O- or bis-O-phosphorylated have been prepared and their properties investigated. The derivatives carrying two phosphate groups were found to be inducers of NO production. In addition, while they were unable to induce significantly the production of interleukin-6 (IL-6) by human PBMC cells, these compounds behaved also as potent antagonists of LPS-induced IL-6 production in the same human cells system. In conclusion, the molecules described here are the first members of an original class of immunobiologically active lipid A mimics based on an acyclic pseudodipeptide backbone carrying only the essential functionalities of the parent lipid A structure (OM-174). As the products exhibit very low endotoxicity and pyrogenicity, this class of lipid A mimics therefore opens a new generation of immunoadjuvants that possibly could reach clinical applications.
    DOI:
    10.1021/jm060482a
  • 作为产物:
    描述:
    R-(3)-苄氧基肉豆蔻酸 在 palladium on activated charcoal N-甲基吗啉氢气三乙胺氯甲酸异丁酯 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 18.5h, 生成 (2R)-5-amino-2-[(R)-3-benzyloxytetradecanoylamino]pentan-1-ol
    参考文献:
    名称:
    Synthesis and Immunobiological Activity of an Original Series of Acyclic Lipid A Mimics Based on a Pseudodipeptide Backbone
    摘要:
    N-delta-L-Homoserinyl-D-ornithinol pseudodipeptides N-acylated with typical Escherichia coli lipid A fatty acid residues and mono-O- or bis-O-phosphorylated have been prepared and their properties investigated. The derivatives carrying two phosphate groups were found to be inducers of NO production. In addition, while they were unable to induce significantly the production of interleukin-6 (IL-6) by human PBMC cells, these compounds behaved also as potent antagonists of LPS-induced IL-6 production in the same human cells system. In conclusion, the molecules described here are the first members of an original class of immunobiologically active lipid A mimics based on an acyclic pseudodipeptide backbone carrying only the essential functionalities of the parent lipid A structure (OM-174). As the products exhibit very low endotoxicity and pyrogenicity, this class of lipid A mimics therefore opens a new generation of immunoadjuvants that possibly could reach clinical applications.
    DOI:
    10.1021/jm060482a
点击查看最新优质反应信息

文献信息

  • IMMUNOMODULATORY COMPOUNDS AND TREATMENT OF DISEASES RELATED TO AN OVERPRODUCTION OF INFLAMMATORY CYTOKINES
    申请人:Bauer Jacques
    公开号:US20090054378A1
    公开(公告)日:2009-02-26
    Method of using immunomodulatory compounds for treating diseases related to an overproduction of inflammatory cytokines, including diseases selected from asthma, atopic dermatitis, allergic rhinitis, prostatitis, inflammatory bowel disease, diabetes, and rhumatoid arthritis, the compounds being of general formula (I): wherein: m and n, independently from each other, are an integer ranging from 1 to 4, X and Y represent —COOH, —O—P(O)(OH) 2 , —O—SO 2 (OH), —NH 2 , —OH, —CONH(CH 2 ) n1 —NH 2 , —CO—NH—CH(COOH)—(CH 2 ) n1 —COOH, —CO—NH—CH(COOH)—(CH 2 ) n1 —NH 2 , —O—CO—(CH 2 ) n1 —NH 2 , —O—CO—(CH 2 ) n1 —CHOH—CH 2 OH, —O—CO—(CH 2 ) n1 —OH, O—CO—(CH 2 ) n1 —COOH, —O—CO—(CH 2 ) n1 —CHO, —O—CO—(CH 2 ) n1 —NH—CO—(CH 2 ) n2 —COOH, R 1 and R 2 each designate an acyl group derived from a saturated or unsaturated, straight- or branched-chain carboxylic acid having from 2 to 18 carbon atoms, which is unsubstituted or bears one to three substituents selected among hydroxyl, dihydroxyphosphoryloxy, alkyl of 2 to 10 carbon atoms, alkoxy of 2 to 10 carbon atoms, acyloxy of 2 to 18 carbon atoms in the acyl moiety, amino, acylamino.
    使用免疫调节化合物治疗与炎症细胞因子过度产生相关的疾病的方法,包括从哮喘、特应性皮炎、过敏性鼻炎、前列腺炎、炎症性肠病、糖尿病和类风湿关节炎中选择的疾病,所述化合物具有通式(I):其中:m和n分别独立于彼此,为1至4之间的整数,X和Y代表—COOH,—O—P(O)(OH)2,—O—SO2(OH),—NH2,—OH,—CONH(CH2)n1—NH2,—CO—NH—CH(COOH)—(CH2)n1—COOH,—CO—NH—CH(COOH)—(CH2)n1—NH2,—O—CO—(CH2)n1—NH2,—O—CO—(CH2)n1—CHOH—CH2OH,—O—CO—(CH2)n1—OH,O—CO—(CH2)n1—COOH,—O—CO—(CH2)n1—CHO,—O—CO—(CH2)n1—NH—CO—(CH2)n2—COOH,R1和R2各自指代从饱和或不饱和、直链或支链的具有2至18个碳原子的羧酸衍生的酰基,该酰基未取代或带有1到3个在2到10个碳原子的烷基、2到10个碳原子的烷氧基、2到18个碳原子的酰氧基在酰基部分、氨基、酰氨基中选择的取代基。
  • Novel acyl-dipeptide-like compounds, a method for preparing the same and pharmaceutical compositions containing such products
    申请人:Bauer Jacques
    公开号:US20060148678A1
    公开(公告)日:2006-07-06
    The invention relates to the field of chemistry and more specifically to the field of medicinal chemistry. The invention is directed to N-acyl-dipeptide-like compounds having the general formula I wherein substituents A, B, X, Y, R 1 , R 2 , and subscripts n, m, p and q have the same meanings as those given in the claims. The invention is equally directed to pharmaceutical compositions containing as an active ingredient at least one compound of general formula I either in acid or salt form with an organic or mineral base. The compounds persuant to the invention display interesting pharmacological properties which make them useful as drugs.
    这项发明涉及化学领域,更具体地涉及药物化学领域。该发明涉及具有通式I的N-酰基二肽类化合物,其中取代基A、B、X、Y、R1、R2以及下标n、m、p和q的含义与索赔中给出的相同。该发明还涉及含有作为活性成分的至少一种通式I化合物的药物组合物,其以有机或矿物质碱的酸或盐形式存在。根据该发明的化合物展示出有趣的药理特性,使它们可用作药物。
  • Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products
    申请人:Bauer Jacques
    公开号:US20050192232A1
    公开(公告)日:2005-09-01
    The present invention is directed in particular to dipeptide-like compounds derived from functionally substituted amino acids, having fatty acid chains bound thereto through amidification of the amine functional groups of said dipeptide-like compounds, one end portion of which bears an accessory functional side chain spacer, with the other end portion being an acid group either in neutral or charged state. Compounds of the present invention have immunomodulating properties like adjuvants, In addition, compounds of the invention can be grafted on a given antigen in order to modulate or tune the immune response or can be equally grafted on a pharmaceutical carrier to enhance the therapeutic effect or targetting thereof. Accordingly, compounds of the invention find use in human and veterinary medicine both as immunogens and diagnostic tools.
    该发明特别涉及类二肽样化合物,这些化合物源自功能性取代的氨基酸,通过酰胺化作用将脂肪酸链结合到所述类二肽样化合物的氨基官能团上,其中一端部分带有辅助功能侧链间隔物,另一端部分是酸基,可以是中性或带电状态。该发明的化合物具有类似佐剂的免疫调节特性。此外,该发明的化合物可以嫁接到给定抗原上,以调节或调整免疫反应,也可以嫁接到药物载体上,以增强治疗效果或靶向效果。因此,该发明的化合物在人类和兽医医学中均可用作免疫原和诊断工具。
  • Acyl pseudodipeptides which carry a functionalised auxialiary arm
    申请人:——
    公开号:US20030203852A1
    公开(公告)日:2003-10-30
    The present invention is directed in particular to dipeptide-like compounds derived from functionally substituted amino acids, having fatty acid chains bound thereto through amidification of the amine functional groups of said dipeptide-like compounds, one end portion of which bears an accessory functional side chain spacer, with the other end portion being an acid group either in neutral or charged state. Compounds of the present invention have immunomodulating properties like adjuvants, In addition, compounds of the invention can be grafted on a given antigen in order to modulate or tune the immune response or can be equally grafted on a pharmaceutical carrier to enhance the therapeutic effect or targetting thereof. Accordingly, compounds of the invention find use in human and veterinary medicine both as immunogens and diagnostic tools.
    本发明特别涉及从功能性取代氨基酸衍生的二肽样化合物,其通过酰胺化作用将脂肪酸链结合到所述二肽样化合物的氨基功能团上,其中一端部分带有附属功能侧链间隔物,另一端部分是酸基,可以是中性或带电状态。本发明的化合物具有类似佐剂的免疫调节性质。此外,本发明的化合物可以嫁接到给定抗原上,以调节或调整免疫应答,或者可以嫁接到药物载体上,以增强治疗效果或靶向作用。因此,本发明的化合物在人类和兽医医学中均可用作免疫原和诊断工具。
  • ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM
    申请人:BAUER Jacques
    公开号:US20130022628A1
    公开(公告)日:2013-01-24
    The present invention is directed in particular to dipeptide-like compounds derived from functionally substituted amino acids, having fatty acid chains bound thereto through amidification of the amine functional groups of said dipeptide-like compounds, one end portion of which bears an accessory functional side chain spacer, with the other end portion being an acid group either in neutral or charged state. Compounds of the present invention have immunomodulating properties like adjuvants. In addition, compounds of the invention can be grafted on a given antigen in order to modulate or tune the immune response or can be equally grafted on a pharmaceutical carrier to enhance the therapeutic effect or targeting thereof. Accordingly, compounds of the invention find use in human and veterinary medicine both as immunogens and diagnostic tools.
    本发明特别针对从功能取代的氨基酸中衍生出来的二肽类化合物,其通过酰胺化作用将脂肪酸链结合到所述二肽类化合物的胺基官能团上,其中一端部分具有辅助功能侧链间隔物,而另一端部分是一个酸基,可以是中性或带电状态。本发明的化合物具有类似佐剂的免疫调节特性。此外,本发明的化合物可以嫁接到给定的抗原上,以调节或调整免疫反应,也可以同样嫁接到药物载体上,以增强其治疗效果或靶向性。因此,本发明的化合物在人类和兽医医学中均可用作免疫原和诊断工具。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐